Bill

Bill > S1338


FL S1338

FL S1338
Prescription Drug Coverage


summary

Introduced
12/20/2019
In Committee
01/08/2020
Crossed Over
Passed
Dead
03/14/2020

Introduced Session

2020 Regular Session

Bill Summary

Authorizing the Office of Insurance Regulation to examine pharmacy benefit managers; requiring health insurers and health maintenance organizations, or pharmacy benefit managers on behalf of health insurers and health maintenance organizations, to annually report specified information to the office; specifying requirements relating to brand-name and generic drugs in contracts between pharmacy benefit managers and pharmacies or pharmacy services administration organizations, etc.

AI Summary

This bill authorizes the Office of Insurance Regulation to examine pharmacy benefit managers and requires health insurers and health maintenance organizations (or their pharmacy benefit managers) to annually report information to the office, such as the number of prescriptions dispensed, the use of retail versus mail-order pharmacies, the use of generic drugs, and the rebates and discounts received. The bill also establishes requirements related to brand-name and generic drugs in contracts between pharmacy benefit managers and pharmacies or pharmacy services administration organizations. Additionally, the bill allows pharmacies to appeal the findings of final audit reports from health insurers or health maintenance organizations.

Committee Categories

Budget and Finance, Business and Industry

Sponsors (4)

Other Sponsors (1)

Banking and Insurance (Senate)

Last Action

Died in Appropriations (on 03/14/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...